Literature DB >> 24882989

Piebaldism with neurofibromatosis type I: a familial case.

Sang-Yeon Park1, Hyun Jung Kim2, Sung Ku Ahn1.   

Abstract

Entities:  

Year:  2014        PMID： 24882989      PMCID： PMC4037687          DOI： 10.5021/ad.2014.26.2.264

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

Review 1.  Piebaldism: an update.

Authors:  Isabelle Thomas; George G Kihiczak; Michael D Fox; Camila K Janniger; Robert A Schwartz
Journal:  Int J Dermatol       Date:  2004-10       Impact factor: 2.736

2.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

3.  A novel KIT mutation results in piebaldism with progressive depigmentation.

Authors:  K A Richards; K Fukai; N Oiso; A S Paller
Journal:  J Am Acad Dermatol       Date:  2001-02       Impact factor: 11.527

4.  Neurofibromatosis 1 and piebaldism: a case report.

Authors:  Y K Tay
Journal:  Dermatology       Date:  1998       Impact factor: 5.366

5.  Ultrastructural study of two patients with both piebaldism and neurofibromatosis 1.

Authors:  T Chang; J D McGrae; K Hashimoto
Journal:  Pediatr Dermatol       Date:  1993-09       Impact factor: 1.588
  5 in total
  3 in total

1.  A novel missense KIT mutation causing piebaldism in one Chinese family associated with café-au-lait macules and intertriginous freckling.

Authors:  Wei-Xue Jia; Xue-Min Xiao; Jian-Bing Wu; Yi-Ping Ma; Yi-Ping Ge; Qi Li; Qiu-Xia Mao; Cheng-Rang Li
Journal:  Ther Clin Risk Manag       Date:  2015-04-21       Impact factor: 2.423

Review 2.  [Piebaldism: a pigmentary anomaly to recognize: about a case and review of the literature].

Authors:  Hajar El Kouarty; Badr Sououd Benjelloun Dakhama
Journal:  Pan Afr Med J       Date:  2016-11-14

3.  Piebaldism Associated with Café-au-lait Macules and Intertriginous Freckling: A Case Report and Review of the Literature.

Authors:  Sevgi Akarsu; Turna İlknur; Ceylan Avcı; Emel Fetil
Journal:  Ann Dermatol       Date:  2019-08-30       Impact factor: 1.444
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.